• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞性视网膜病变的保护与儿童 HbF 水平升高和羟基脲的使用有关。

Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children.

机构信息

Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.

出版信息

Br J Haematol. 2013 May;161(3):402-5. doi: 10.1111/bjh.12238. Epub 2013 Feb 6.

DOI:10.1111/bjh.12238
PMID:23384083
Abstract

Elevated foetal haemoglobin (HbF) levels are protective against some manifestations of sickle cell anaemia but the impact on retinopathy is unknown. We report on 123 children with HbSS, 10.6% of whom developed retinopathy. Independent of hydroxycarbamide, children with a HbF <15% had 7.1-fold (95% confidence interval, 1.5-33.6) higher odds of developing retinopathy. In children treated with hydroxycarbamide, those with retinopathy had lower HbF levels compared to children without retinopathy (9% vs. 16%; P = 0.005). We report a protective benefit of elevated HbF regarding retinopathy, and our data suggests induction of HbF with hydroxycarbamide may prevent retinopathy in children.

摘要

胎儿血红蛋白 (HbF) 水平升高可预防镰状细胞贫血的某些表现,但对视网膜病变的影响尚不清楚。我们报告了 123 名 HbSS 患儿,其中 10.6%发生了视网膜病变。独立于羟基脲,HbF<15%的儿童发生视网膜病变的几率高 7.1 倍(95%置信区间,1.5-33.6)。在接受羟基脲治疗的儿童中,有视网膜病变的儿童的 HbF 水平低于无视网膜病变的儿童(9%对 16%;P=0.005)。我们报告了 HbF 升高对视网膜病变的保护作用,我们的数据表明,用羟基脲诱导 HbF 可能预防儿童的视网膜病变。

相似文献

1
Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children.镰状细胞性视网膜病变的保护与儿童 HbF 水平升高和羟基脲的使用有关。
Br J Haematol. 2013 May;161(3):402-5. doi: 10.1111/bjh.12238. Epub 2013 Feb 6.
2
Elevated fetal haemoglobin levels are associated with decreased incidence of retinopathy in adults with sickle cell disease.胎儿血红蛋白水平升高与镰状细胞病成人中视网膜病变发生率降低有关。
Br J Haematol. 2018 Dec;183(5):807-811. doi: 10.1111/bjh.15617. Epub 2018 Nov 12.
3
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.羟基脲改变镰状细胞贫血患儿的红细胞基因表达。
Br J Haematol. 2012 Apr;157(2):240-8. doi: 10.1111/j.1365-2141.2012.09061.x. Epub 2012 Feb 24.
4
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.早期采用个体化药代动力学指导剂量的羟基脲(羟脲)治疗可使镰状细胞贫血儿童持续且几乎全细胞表达胎儿血红蛋白。
Br J Haematol. 2021 Aug;194(3):617-625. doi: 10.1111/bjh.17663. Epub 2021 Jul 5.
5
Soluble CD163 levels in children with sickle cell disease.镰状细胞病患儿可溶性 CD163 水平。
Br J Haematol. 2011 Apr;153(1):105-10. doi: 10.1111/j.1365-2141.2011.08580.x. Epub 2011 Feb 20.
6
Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.羟基脲对巴西镰状细胞贫血患者群体的影响。
Am J Hematol. 2005 Mar;78(3):243-4. doi: 10.1002/ajh.20293.
7
Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.羟基脲治疗镰状细胞-β地中海贫血症中的脑血管事件:意大利成人单中心前瞻性研究。
Am J Hematol. 2013 Nov;88(11):E261-4. doi: 10.1002/ajh.23531. Epub 2013 Aug 30.
8
Haemoglobin F modulation in childhood sickle cell disease.儿童镰状细胞病中的胎儿血红蛋白调节
Br J Haematol. 2009 Feb;144(3):308-16. doi: 10.1111/j.1365-2141.2008.07482.x. Epub 2008 Nov 20.
9
Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.科威特镰状细胞病患者且基线胎儿血红蛋白(HbF)水平升高者对羟基脲的反应。
Am J Hematol. 2015 Jul;90(7):E138-9. doi: 10.1002/ajh.24027.
10
A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.羟基脲治疗期间镰状细胞贫血患儿具有临床意义的胎儿血红蛋白阈值。
Am J Hematol. 2017 Dec;92(12):1333-1339. doi: 10.1002/ajh.24906. Epub 2017 Sep 28.

引用本文的文献

1
Sickle cell retinopathy in pediatric patients: exploring correlations and predictive factors.小儿镰状细胞视网膜病变:探索相关性及预测因素
Graefes Arch Clin Exp Ophthalmol. 2025 Aug 23. doi: 10.1007/s00417-025-06946-y.
2
Clinical and laboratory risk factors for sickle cell retinopathy and maculopathy: a scoping review of the current evidence.镰状细胞视网膜病变和黄斑病变的临床及实验室风险因素:当前证据的范围综述
Haematologica. 2025 May 1;110(5):1092-1104. doi: 10.3324/haematol.2024.286420. Epub 2024 Dec 19.
3
Computational screening of phytochemicals present in some Nigerian medicinal plants against sickle cell disease.
计算筛选尼日利亚药用植物中某些植物化学物质对镰状细胞病的作用。
Sci Rep. 2024 Nov 1;14(1):26368. doi: 10.1038/s41598-024-75078-w.
4
A Study of the Prevalence and Pattern of Sickle Cell Retinopathy among Eye Clinic Attendees in a Nigerian Tertiary Hospital.尼日利亚一家三级医院眼科门诊患者镰状细胞视网膜病变的患病率及模式研究。
Niger Med J. 2023 May 11;64(2):293-301. eCollection 2023 Mar-Apr.
5
Role of hydroxyurea therapy in the prevention of organ damage in sickle cell disease: a systematic review and meta-analysis.羟基脲治疗在预防镰状细胞病器官损伤中的作用:系统评价和荟萃分析。
Syst Rev. 2024 Feb 8;13(1):60. doi: 10.1186/s13643-024-02461-z.
6
Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study.成人镰状细胞病患者视网膜病变的自然史和进展速度:一项为期 11 年的随访研究。
Blood Adv. 2023 Jul 11;7(13):3080-3086. doi: 10.1182/bloodadvances.2022009147.
7
Risk factors associated with sickle cell retinopathy: findings from the Cooperative Study of Sickle Cell Disease.与镰状细胞视网膜病变相关的危险因素:镰状细胞病合作研究的结果
Int J Retina Vitreous. 2022 Sep 22;8(1):68. doi: 10.1186/s40942-022-00419-8.
8
Action on sickle cell retinopathy: the time is now.应对镰状细胞视网膜病变:刻不容缓。
Eye (Lond). 2022 Jun;36(6):1138-1139. doi: 10.1038/s41433-021-01918-y. Epub 2022 Jan 28.
9
Hemoglobinopathies: ocular manifestations in children and adolescents.血红蛋白病:儿童和青少年的眼部表现
Ther Adv Ophthalmol. 2021 Jun 30;13:25158414211022882. doi: 10.1177/25158414211022882. eCollection 2021 Jan-Dec.
10
Surgical and Medical Perioperative Management of Sickle Cell Retinopathy: A Literature Review.镰状细胞视网膜病变的手术和医疗围手术期管理:文献回顾。
Int Ophthalmol Clin. 2020 Fall;60(4):77-87. doi: 10.1097/IIO.0000000000000323.